C₂N Diagnostics is a specialty diagnostics company with a vision to bring Clarity Through Innovation®.
Location: United States, Missouri, Saint Louis
Employees: 11-50
Total raised: $30M
Funding Rounds 2
| Date | Series | Amount | Investors |
| 30.09.2024 | - | $15M | - |
| 07.03.2024 | - | $15M | - |
Mentions in press and media 4
| Date | Title | Description |
| 30.09.2024 | C2N Diagnostics Receives $15M Program Related Investment from GHR Foundation | C2N Diagnostic, a St Louis, MO-based company which specializes in developing Alzheimer’s disease-specific fluid biomarker tests, received a $15M program-related investment from GHR Foundation (GHR). The company intends to use the funds for ... |
| 26.09.2024 | C2N Receives $7.025M Funding | C2N, a St. Louis, MO-based diagnostics company developing Precivity blood tests, raised $7.025M in funding. The round was led by Alzheimer’s Drug Discovery Foundation’s (ADDF) Diagnostics Accelerator. The company intends to use the funds to... |
| 07.03.2024 | C₂N Diagnostics Receives Up To USD15M Investment From Eisai | C₂N Diagnostics, a St. Louis, MO-based brain health diagnostics company, received up to USD15M in investment from Eisai. The company intends to use the funds to expand the availability, accessibility and use of blood biomarker tests for the... |
| 17.02.2023 | C2N Diagnostics Announces Follow-on Investment from GHR Foundation as It Builds on Success in Novel Diagnostics to Aid in Alzheimer’s Disease Fight | C2N Diagnostics, LLC, a leader in advanced brain health diagnostics, announced it has received a $15 million program-related investment from GHR Foundation. This financing, an expansion of GHR’s initial $20 million program-related investmen... |